{
    "cancelStatus": "1",
    "cancelDate": "2012-11-26",
    "cancelReason": [
        "838"
    ],
    "licid": "06015862",
    "validDate": "2011-01-10 00:00:00.000",
    "issueDate": "2006-01-10 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHAS0601586201",
    "prodNameC": "常盈胰島素生長因子(IGF-1)",
    "prodNameE": "DSL Insulin like growth factor (IGF-1)IRMA",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "A. IGF-I Standards: (Lyophilized)Six vials, labeled A-F, containing concentrations of approximately 0,8,30,100,300, and 1000 ng\/mL (1.1-130 nmol\/L) of IGF-I in a protein-based (BSA) buffer with a non-mercury preservative.B. Anti-IGF-I [I-125] Reagents: (RED)One bottle, 22 mL, containing < 10μCi (370kBq) of [I-125]-labeled anti-IGF-I in a protein –based (BSA) bufferC. Anti-IGF-I Coated Tubes: (METALLIC LIHGT GREEN RIM)One hundred (100) plastic tubes with Anti-IGF-I immunoglobulin immobilized to the inside wall of each tube.D. Sample Diluent:One bottle, 105 mL, containing sample buffer with sodium azide as a preservative.E. Wash Concentrate:One bottle, 60 mL, containing buffer with a non-ionic detergent.F. IGF-I Controls: (Lyophilized)Two vials, Level I and Level II, containing Low and high concentrations of IGF-I in a protein-based (BSA) buffer with non-mercury preservative."
    ],
    "restraintItemsCode": [
        "R02",
        "R94"
    ],
    "applicantName": "常盈實業股份有限公司",
    "applicantAddr": "台北市北投區永興路一段49號",
    "medClass": "2",
    "efficacy": "利用放射性體外免疫定量方法檢測臨床標本血液\/血漿中之IGF-1。 ",
    "mdFormat": "DSL-2800: 100 tubes",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "A",
            "mdKindMCodeName": "A 臨床化學及臨床毒理學",
            "mdKindDCode": "A.1370",
            "mdKindDCodeName": "A.1370 人體生長激素試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "DIAGNOSTIC SYSTEMS LABORATORIES, INC.",
            "factoryAddr": "445 MEDICAL CENTER BOULEVARD WEBSTER, TEXAS 77598 U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS1077000",
            "factoryInfo": "1",
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "A. IGF-I Standards: (Lyophilized)Six vials, labeled A-F, containing concentrations of approximately 0,8,30,100,300, and 1000 ng\/mL (1.1-130 nmol\/L) of IGF-I in a protein-based (BSA) buffer with a non-mercury preservative.B. Anti-IGF-I [I-125] Reagents: (RED)One bottle, 22 mL, containing < 10μCi (370kBq) of [I-125]-labeled anti-IGF-I in a protein –based (BSA) bufferC. Anti-IGF-I Coated Tubes: (METALLIC LIHGT GREEN RIM)One hundred (100) plastic tubes with Anti-IGF-I immunoglobulin immobilized to the inside wall of each tube.D. Sample Diluent:One bottle, 105 mL, containing sample buffer with sodium azide as a preservative.E. Wash Concentrate:One bottle, 60 mL, containing buffer with a non-ionic detergent.F. IGF-I Controls: (Lyophilized)Two vials, Level I and Level II, containing Low and high concentrations of IGF-I in a protein-based (BSA) buffer with non-mercury preservative.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "41997898-3CD1-4D5E-94D8-AA7716917959"
}